Skip to main content

Table 6 Simple Tobit regression (left ear)

From: Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity

Frequency (Hz)

No. of non-responses

Variables

Estimate of coefficient (SE); p-value

Age

HIV seropositive

NCD

LFPTT

125

1

0.36 (0.12); 0.01

0.95 (2.77); 0.73

3.51 (3.14 (0.26)

250

0

0.41 (0.13); 0.01

0.71 (3.04); 0.82

3.5 (3.42); 0.31

500

0

0.4 (0.14); 0.01

0.36 (3.28); 0.91

4 (3.76); 0.28

MFPTT

1000

0

0.42 (0.16); 0.01

0.88 (3.56); 0.8

3.21 (4.02); 0.42

2000

0

0.55 (0.16); 0.01

2.21 (3.66); 0.55

3.25 (4.11); 0.43

HFPTT

4000

1

0.91 (0.17); 0.01

7.14 (4.29); 0.09

7.26 (4.89); 0.14

8000

0

1.11 (0.2); 0.01

9.77 (5.07); 0.05

1.62 (5.77); 0.01

9000

1

1.33 (0.19); 0.01

16.11 (4.92); 0.001

4.13 (5.82); 0.48

EHFPTT

10,000

3

1.64 (0.19); 0.01

21.23 (5.28); 0.01

5.25 (6.58); 0.42

11,200

5

1.95 (0.19); 0.01

25.3 (5.61); 0.01

0.54 (7.15); 0.94

12,500

12 (14.6%)

2.02 (0.19); 0.01

26.4 (5.76); 0.01

− 1.81 (7.36); 0.81

14,000

23 (28%)

1.85 (0.21); 0.01

22.37 (5.76); 0.01

4.38 (7.16); 0.54

16,000

50 (61%)

0.92 (0.23); 0.01

12.93 (4.81); 0.01

6.87 (5.67); 0.22

18,000

68 (83%)

0.71 (0.46); 0.13

6.1 (9.42); 0.52

11.85 (9.62); 0.22

20,000

73 (89%)

0.23 (0.21); 0.26

1.81 (4.34);0.68

4.74 (4.99);0.34

  1. LFPTT, Low frequency pure tone thresholds; MFPTT, Mid frequency pure tone thresholds; HFPTT, High frequency pure tone thresholds; EHFPTT, Extended high frequency pure tone thresholds; NCD, Hypertension and Diabetes